Amber Kornely, NP
Family · Green Bay, WINPI 1942725825
Payments from drug & device makers
Across 15 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$145
- E.r. Squibb & Sons, L.L.C.$135
- Sanofi-aventis U.S. LLC$99
- Merck$36
- Daiichi Sankyo Inc.$22
- Sumitomo Pharma America, Inc.$22
- plus $81 from 5 others
What the payments were for
- Food & beverage$44182%
- Education$9918%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $145 |
| E.r. Squibb & Sons, L.L.C. | 3 | $135 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Merck | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Bayer | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
How this compares
$540 in reported general payments places this provider in the 75th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 40 | $654,602 |
| Lenalidomide | 25 | $365,532 |
| IbrancePalbociclib | 13 | $208,836 |
| BrukinsaZanubrutinib | 13 | $194,237 |
| Abiraterone Acetate | 15 | $45,553 |
| EliquisApixaban | 23 | $13,063 |
| Imatinib Mesylate | 23 | $8,206 |
| Exemestane | 22 | $2,206 |
| Anastrozole | 103 | $1,820 |
| Tamoxifen Citrate | 56 | $1,757 |
| Ondansetron Hcl | 24 | $640 |
| Acyclovir | 37 | $537 |
| Hydroxyurea | 15 | $507 |
| Gabapentin | 29 | $324 |
| Dexamethasone | 28 | $312 |
Paid to pharmacies, not to this prescriber.
Other family in Green Bay
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Diane VanderlinGreen Bay$5K
- Stephanie OffordMilwaukee$763K
- Laura SwobodaMenomonee Falls$111K
- Melissa BellePrentice$62K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.